Rosacea Therapy
NDC Package 73503-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Rosacea Therapy is a . Marketed by Psodex Usa Inc, this product is identified by NDC 73503-009 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
73503-009-01
Package Description
1000 BOTTLE, PUMP in 1 BOX / 1000 mL in 1 BOTTLE, PUMP (73503-009-00)
Product Code
11-Digit Billing Format
73503000901
RxNorm Crosswalk
  • RxCUI: 2672350 - azelaic acid 5 % / tranexamic acid 1 % Topical Cream
  • RxCUI: 2672350 - azelaic acid 50 MG/ML / tranexamic acid 10 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Rosacea Therapy Moisturizing
Dosage Form
-

Regulatory & Marketing

Labeler Name
Psodex Usa Inc
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2024
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73503-009-01 identifies a specific commercial package of 1000 bottle, pump in 1 box / 1000 ml in 1 bottle, pump (73503-009-00) of Rosacea Therapy Moisturizing, labeled by Psodex Usa Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Psodex Usa Inc on January 01, 2024. The current certification is valid through December 31, 2025.

How is this Psodex Usa Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73503000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73503-009-01
11-Digit CMS (5-4-2)
73503-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.